Suchergebnisse - "Samuel Egieyeh"

PubPharm (6)

1

State-of-the-art strategies to prioritize Mycobacterium tuberculosis drug targets for drug discovery using a subtractive genomics approach

in: Frontiers in Drug Discovery | 2023

von Adetutu Akinnuwesi | Samuel Egieyeh | Ruben Cloete

2

Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of

in: Antioxidants | 2022

von Ninon G. E. R. Etsassala | Jelili A. Badmus | Jeanine L. Marnewick | +4

3

Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2).

in: PLoS ONE | 2021

von Samuel Egieyeh | Elizabeth Egieyeh | Sarel Malan | +2

4

A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa

in: Viruses | 2021

von Admire Dube | Samuel Egieyeh | Mohammed Balogun

5

Predictive classifier models built from natural products with antimalarial bioactivity using machine learning approach.

in: PLoS ONE | 2018

von Samuel Egieyeh | James Syce | Sarel F Malan | +1

6

Exploration of Scaffolds from Natural Products with Antiplasmodial Activities, Currently Registered Antimalarial Drugs and Public Malarial Screen Data

in: Molecules | 2016

von Samuel Egieyeh | James Syce | Alan Christoffels | +1

1
[1]